Skip to main content
2024 Midyear Clinical Meeting & Exhibition Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certified Pharmacy Executive Leader
Certified Pharmacy Executive Leader
Digital Health & Informatics
Digital Health & Informatics
Diversity, Equity and Inclusion
Diversity, Equity and Inclusion
Health & Wellness
Health & Wellness
Opioids & Pain Management
Opioids & Pain Management
Sterile Compounding
Sterile Compounding
Back
Handout

Educational Sessions

Getting the Skinny on Existing and Emerging Therapies for Non-Alcoholic Fatty Liver Disease

Wednesday, December 11, 2024
4:00 PM – 5:00 PM  
Location: MCCNO, Room 356, Level 3
CE Credits: 1.00 contact hours
Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists
Activity #: 0204-0000-24-350-L01-P
Activity Type: Knowledge-based
Target Audience: Pharmacist

Learning Objectives:

  • Describe non-alcoholic fatty liver disease (NAFLD) and the current management strategy.
  • Identify the limitations of current medications used off-label for NAFLD.
  • Discuss the advantages and disadvantages of emerging therapies for NAFLD.